PTU-085 Clinical benefits of the use of infliximab (INF) and adalumimab (ADA) therapeutic drug level monitoring in a uk district general hospital | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Inflammatory Bowel Disease I

PTU-085 Clinical benefits of the use of infliximab (INF) and adalumimab (ADA) therapeutic drug level monitoring in a uk district general hospital

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Chan C, Padmanabhan H, Steed H, et al

PTU-085 Clinical benefits of the use of infliximab (INF) and adalumimab (ADA) therapeutic drug level monitoring in a uk district general hospital

Gut 2015;64:A98.